Stock News

PharmaDrug Inc. Announces Strategic Plans for Advancing PD-001 Clinical Development Toronto, Ontario–(Newsfile Corp. – August 28, 2024) PharmaDrug Inc. (CSE: PHRX) (OTC: LMLLF) (“PharmaDrug” or the “Company”), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics and previously approved drugs, is pleased to announce its…

One of Australia’s Leading Footwear Retailers with 10+ Brands TORONTO, ON / ACCESSWIRE / August 28, 2024 Adcore Inc. (the “Company” or “Adcore”) (TSX:ADCO)(OTCQX:ADCOF)(FSE:ADQ), a leading E-commerce advertising management and automation platform to leverage digital marketing in an effortless and accessible way (“Effortless Marketing”), today announced that it has been appointed by Munro Footwear Group…

Levi & Korsinsky Investigates Syros Pharmaceuticals What’s Going on with Syros Pharmaceuticals? So, here’s the scoop. Levi & Korsinsky, those fancy folks known for their investigations, have decided to turn their eagle eyes towards Syros Pharmaceuticals, Inc. Why, you ask? Well, it seems there are suspicions of some shadiness going on in the world of…

Welcome to the World of Virax Biolabs Group Limited! Exciting News from Virax Biolabs Group Limited It’s always a great day when we hear about advancements in biotechnology, especially when it comes to the detection and diagnosis of viral diseases. That’s why we were thrilled to learn that Virax Biolabs Group Limited has recently entered…

Welcome to the Citi Trends Disaster Zone Where 2Q24 Results Leave Us in Tears When Disappointing Turns into Devastating Alright folks, grab your tissues and brace yourselves, because Citi Trends’ 2Q24 results are in, and let’s just say they’re not exactly a cause for celebration. We’re talking significant operational losses, inventory markdowns, and decelerating comparable…

Impact of Meta’s Decision on Entravision Communications Corporation A Heartfelt Reflection As news of Meta’s (Facebook) decision to end its relationship with Entravision Communications Corporation broke on March 5, 2024, investors were left in a state of shock and uncertainty. The ripple effect of this announcement has sent waves across the financial market, leaving many…

Completed Divestiture of China Operations and IND Clearance for Uliledlimab Paves the Way for Exciting Developments at I-Mab I-Mab, a global biotech company focused on developing immunotherapies for cancer treatment, recently announced significant milestones that are set to propel the company forward in the coming years. One of the key highlights is the completed divestiture…

The Class Action Lawsuit Against Verve Therapeutics: What You Need to Know Class Definition On August 28, 2024, Bronstein, Gewirtz & Grossman, LLC announced that a class action lawsuit has been filed against Verve Therapeutics, Inc. (NASDAQ:VERV) and certain of its officers. The lawsuit aims to recover damages for alleged violations of federal securities laws…